CME Webcast Educates Learners on Lung Cancer Staging

OSUWexnerbloglogo2014 CME Webcast Educates Learners on Lung Cancer Staging. On this program, we’re going to update you on the approach to lung cancer staging. Joining on moderator is our lung cancer expert from the Division of Hematology and Medical Oncology, Clinical Instructor of Internal Medicine, Dr. Jean Bustamante Alvarez.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: RECOGNIZE the importance of lung cancer staging and the need for a multidisciplinary approach; and IDENTIFY the minimally necessary studies that will be necessary to stage a patient with lung cancer.

You’ll also learn about the following:

  • Racial disparities in lung cancer diagnosis and survival
  • Staging small cell lung cancer
  • Surgery versus stereotactic ablative radiotherapy
  • Stereotactic ablative radiotherapy
  • When PET-CT can miss lung cancer

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Lung Diseases They Didn’t Teach You About in Medical School

OSUWexnerbloglogo2014 Lung Diseases They Didn’t Teach You About in Medical School. On this CME webcast, we’re going to talk about 10 lung diseases that you probably didn’t learn about in medical school, either because they weren’t discovered at the time, we didn’t have good tests for at the time, or their importance wasn’t known about at the time.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: DIAGNOSE and treat recently discovered genetic lung diseases; and DIAGNOSE and treat uncommon pulmonary infections.

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

CME Webcast Discusses New Therapies for Lung Cancer

OSUWexnerbloglogo2014 CME Webcast Discusses New Therapies for Lung Cancer. On this CME webcast, we’re going to update you on the medical management of lung cancer and focus on non-small cell lung cancer. Joining our moderator in the studio is medical oncologist at the James Cancer Hospital and Professor of Internal Medicine from the Ohio State University, Dr. David Carbone.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: Review some of the latest practice-changing findings in the management of lung cancer; and Understand the basic principles of workup and initial lung cancer management decisions.

You’ll also learn about the following:

  • Classifying non-small cell lung cancer
  • Common side effects of driver-targeted therapies
  • What the primary care physician needs to know about co-managing patients taking driver-targeted therapy

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

 

On-line Enduring Material Teaches on Adrenal Nodules

OSUWexnerbloglogo2014 On-line Enduring Material Teaches on Adrenal Nodules. Pheochromocytomas are fairly rare with about 1,000 cases in the U.S. every year but overall, adrenal tumors are common, and you can find one in about every 20 patients who undergo abdominal CT scans. Most of these adrenal tumors are benign and require no treatment but knowing which ones are consequential and which ones are inconsequential can be a challenge. On this CME webcast, to show you how to manage the incidentally identified adrenal tumor is surgical oncologist and Assistant Professor of Surgery at the Ohio State University, we have Dr. Drew Shirley.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: UNDERSTAND the imaging characteristics used to determine treatment strategies for adrenal nodules; and USE biochemical tests to aid in the diagnosis of functional adrenal nodules.

You’ll also learn about the following:

  • Causes of adrenal nodules
  • Which adrenal nodule need to be biopsied
  • Familial syndromes involving adrenal tumors
  • Incidental adrenal nodules found when staging lung cancer
  • Performing adrenal nodule needle biopsy and FNA
  • What to expect during and after adrenal surgery
  • Approach to adrenal hemorrhage
  • Radiographic imaging follow-up of adrenal nodules
  • Laboratory follow-up of adrenal nodules in patients with hypertension

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

On-line Enduring Material Provides Guidance on Cancer Prevention

OSUWexnerbloglogo2014 On-line Enduring Material Provides Guidance on Cancer Prevention. Most cancers can be prevented by changing behaviors at an early age, by appropriate vaccinations, and by detection of pre-cancerous conditions. On this CME webcast, we are going to show you how to prevent cancer in your own patients. Joining our moderator in the studio are cancer prevention experts from the Ohio State University. Dr. Electra Paskett is a Professor and the Director of the Division of Cancer Prevention and Control. And Dr. Darrell Gray is a gastroenterologist and an Assistant Professor of Internal Medicine.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: UNDERSTAND evidence-based cancer prevention recommendations; and DEVELOP ways to integrate evidence-based cancer prevention and early detection recommendations in clinical practice.

You’ll also learn about the following:

  • Brief overview of causes of cancer
  • Screening for pre-cancerous conditions
  • Lung cancer screening programs
  • Improving colon cancer screening rates
  • Addressing racial disparities in childhood obesity
  • Experiences with cancer screening in Appalachia

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.